Inclusion in ESG Indexes

Environmental, social, and governance (ESG) indexes are used to facilitate an investment stance that entails considering and evaluating how the target company is exercising its social responsibility in addition to its financial performance and growth potential when making investment decisions. Daiichi Sankyo believes that responsible corporate activities are indivisible from its business activities and has continued to advance these activities in an integrated manner. This stance has been acknowledged, resulting in the Company's inclusion in ESG indexes.

Daiichi Sankyo Listed on the 2018 Dow Jones Sustainability Indices World Index (DJSI World) for the Second Consecutive Year

Dow Jones Indices

The DJSI is managed cooperatively by S&P Dow Jones Indices LLC, of the United States, and RobecoSAM AG, of Switzerland. This ESG index evaluates the sustainability of a company and provides important criterion for the selection of investment targets by investors.
The Company has been listed on the 2018 DJSI World for the second consecutive year and DJSI Asia Pacific in for the ninth consecutive year.
The Company is the only Japanese company among the seven pharmaceutical companies in the sector to be listed on DJSI World, just as the last year among the eight companies.

Areas in which Daiichi Sankyo was rated the highest among pharmaceutical companies

Economic Dimension • Operational Eco-Efficiency
Social Dimension • Corporate Citizenship and Philanthropy
• Occupational Health and Safety

Topics

The first Japanese company to be selected for the "Silver Class" in the pharmaceutical sector

RobecoSAM

The Company has been selected for the "Silver Class" of Swiss-based RobecoSAM Sustainability award in the pharmaceutical sector. The Silver Class distinction is given to the companies within the range of one to five percent of the industry's top-performing company’s score. Daiichi Sankyo was recognized for the entire Environmental Dimension including Climate Strategy. As well, the Company was also recognized for its strong performance in the area of Codes of Business Conduct and Materiality in the Economic Dimension, Occupational Health and Safety, Health Outcome Contribution and Strategy to Improve Access to Drugs in the Social Dimension. There were two companies selected in the Gold Class for pharmaceuticals along with four Silver Class companies including Daiichi Sankyo, and two in the Bronze Class.

Press Releases

Selected consecutively for ten years

FTSE4Good

An index that reflects the performance of companies demonstrating strong environmental, society, and governance (ESG) practices, established by FTSE Russell, a global index provider and wholly-owned subsidiary of the London Stock Exchange Group plc. The FTSE4Good index series is used as a benchmark for investors to identify corporations that have overall good performance in ESG initiatives. The Company has been selected for ten consecutive years as a component of the FTSE4Good Global Index from 2009.

Selected consecutively for two years

FTSE Blossom Japan

An industry-neutral benchmark that reflects the performances of companies demonstrating strong environmental, society, and governance (ESG) practices in Japan, established by FTSE Russell, a global index provider and wholly-owned subsidiary of London Stock Exchange Group plc. The FTSE Blossom Japan Index is used for sustainable investments and widely applied in creating and assessing other financial products and funds. It has been newly selected by the Government Pension Investment Fund (GPIF) as an ESG Index. Through third-party screening, the Company has fulfilled the requirements to enter the FTSE Blossom Japan Index, and has been selected two years in a row for this index.

Selected consecutively for ten years

MS-SRI

Morningstar Japan KK selects 150 companies each year from among Japanese listed companies. This index includes those companies that have been regarded as excellent from the perspectives of governance, environmental, social, and human resources development. The Company has been included in this index for ten consecutive years beginning with 2008.

Selected consecutively for three years

sjnk-am

The SNAM Sustainability Index is an SRI fund managed by Sompo Japan Nipponkoa Asset Management Co., Ltd., aimed at pension funds and institutional investors that invest in a wide range of companies highly rated in terms of ESG factors (environment, society, governance). The Company has been included in this index for three consecutive years.

Selected for the first time

The MSCI Japan Empowering Women (WIN) Select Index is one of three indexes selected by the Government Pension Investment Fund (GPIF) as an ESG Index in Japanese stock. It assesses gender diversity in corporations such as the female ratio among new recruits, employees, average work years and the ratio of female executives, and comprises corporations that excel in these factors. In June 2018, the Company was included in this index for the first time.

(As of the end of September 30, 2018)

ESG Data

【Message from Vice President of CSR Department】

Daiichi Sankyo has been included in the above indices, which are all well-known ESG indices.
I believe that this accomplishment is due to the recognition of our efforts to fulfill our corporate mission and integrate responsible corporate activities into our business activities based on the recognition that they are indivisible.
At the same time, however, we realize that the expectations for initiatives related to sustainability, ESG and related information disclosure are rising rapidly and on a global scale. In Japan, for example, we have recently witnessed the establishment of Japan’s Stewardship Code and the Corporate Governance Code as well as the release of the final report of the Ito Review’s “Competitiveness and Incentives for Sustainable Growth: Building Favorable Relationships between Companies and Investors” Project. These developments have stimulated further growth in the demand for more sincere corporate activities, more comprehensive information disclosure, and more active communication with stakeholders, making response to this demand a must for companies.
Under these circumstances, we began issuing the Value Report in 2013 as a communication tool to facilitate understanding of the Group’s corporate value, growth potential, and capacity for business continuity among shareholders, investors, healthcare professionals, consumers, Group employees, and our various other stakeholders. Through the Value Report, we are providing comprehensive disclosure of information related to business activities as well as ESG factors while also encouraging more active communication with stakeholders.